These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2269326

  • 1. Evidence of IgG-mediated enhancement of the antibody response in vivo without complement activation via the classical pathway.
    Wiersma EJ, Nose M, Heyman B.
    Eur J Immunol; 1990 Dec; 20(12):2585-9. PubMed ID: 2269326
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of the antibody response to protein antigens by specific IgG under different experimental conditions.
    Wiersma EJ.
    Scand J Immunol; 1992 Aug; 36(2):193-200. PubMed ID: 1502494
    [Abstract] [Full Text] [Related]

  • 3. Complement activation is not required for IgG-mediated suppression of the antibody response.
    Heyman B, Wiersma E, Nose M.
    Eur J Immunol; 1988 Nov; 18(11):1739-43. PubMed ID: 3060362
    [Abstract] [Full Text] [Related]

  • 4. Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.
    Couderc J, Kazatchkine MD, Ventura M, Duc HT, Maillet F, Thobie N, Liacopoulos P.
    J Immunol; 1985 Jan; 134(1):486-91. PubMed ID: 3917282
    [Abstract] [Full Text] [Related]

  • 5. Dual immunoregulatory effects of monoclonal IgG-antibodies: suppression and enhancement of the antibody response.
    Wiersma EJ, Coulie PG, Heyman B.
    Scand J Immunol; 1989 Apr; 29(4):439-48. PubMed ID: 2470138
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice.
    Coulie PG, Van Snick J.
    Eur J Immunol; 1985 Aug; 15(8):793-8. PubMed ID: 4029257
    [Abstract] [Full Text] [Related]

  • 7. The failure to show a necessary role for C3 in the in vitro antibody response.
    Waldmann H, Lachmann PJ.
    Eur J Immunol; 1975 Mar; 5(3):185-93. PubMed ID: 1086224
    [Abstract] [Full Text] [Related]

  • 8. Clonal anergy of memory B cells in epitope-specific regulation.
    Galelli A, Charlot B.
    J Immunol; 1990 Oct 15; 145(8):2397-405. PubMed ID: 1698854
    [Abstract] [Full Text] [Related]

  • 9. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo.
    Kohm AP, Sanders VM.
    J Immunol; 1999 May 01; 162(9):5299-308. PubMed ID: 10228005
    [Abstract] [Full Text] [Related]

  • 10. Rheumatoid factor autoantibody-binding site: a molecular analysis using monoclonal antibodies with dual anti-TNP and anti-IgG activities.
    Reininger L, Spertini F, Shibata T, Jaton JC, Izui S.
    Eur J Immunol; 1989 Nov 01; 19(11):2123-30. PubMed ID: 2513210
    [Abstract] [Full Text] [Related]

  • 11. Influence of carriers on the development and localization of anti-2,4,6-trinitrophenyl (TNP) antibody-forming cells in the murine spleen. II. Suppressed antibody response to TNP-Ficoll after elimination of marginal zone cells.
    Claassen E, Kors N, Van Rooijen N.
    Eur J Immunol; 1986 May 01; 16(5):492-7. PubMed ID: 2938975
    [Abstract] [Full Text] [Related]

  • 12. Double immunocytochemical staining in the study of antibody-producing cells in vivo. Combined detection of antigen specificity (anti-TNP) and (sub)class of intracellular antibodies.
    Van Rooijen N, Kors N.
    J Histochem Cytochem; 1985 Mar 01; 33(3):175-8. PubMed ID: 2579119
    [Abstract] [Full Text] [Related]

  • 13. Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement.
    van Dam AP, Hack CE.
    Immunology; 1987 Jun 01; 61(2):105-10. PubMed ID: 3596635
    [Abstract] [Full Text] [Related]

  • 14. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
    Sumida T, Taniguchi M.
    J Immunol; 1985 Jun 01; 134(6):3675-81. PubMed ID: 3157746
    [Abstract] [Full Text] [Related]

  • 15. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
    Bliss J, Van Cleave V, Murray K, Wiencis A, Ketchum M, Maylor R, Haire T, Resmini C, Abbas AK, Wolf SF.
    J Immunol; 1996 Feb 01; 156(3):887-94. PubMed ID: 8558014
    [Abstract] [Full Text] [Related]

  • 16. Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response.
    Böttger EC, Metzger S, Bitter-Suermann D, Stevenson G, Kleindienst S, Burger R.
    Eur J Immunol; 1986 Oct 01; 16(10):1231-5. PubMed ID: 2945728
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of trinitrophenyl-specific humoral response to TNP proteins as the result of carrier chlorination.
    Marcinkiewicz J, Olszowska E, Olszowski S, Zgliczynski JM.
    Immunology; 1992 Jul 01; 76(3):385-8. PubMed ID: 1382040
    [Abstract] [Full Text] [Related]

  • 18. T cell regulation of immunoglobulin class expression in the B cell response to TNP-Ficoll: characterization of the T cell responsible for preferential enhancement of the IgG2a response.
    Mongini PK, Longo DL, Paul WE.
    J Immunol; 1984 Apr 01; 132(4):1647-53. PubMed ID: 6230389
    [Abstract] [Full Text] [Related]

  • 19. Immunomodulatory effects of C3bgp on the antibody response to hemocyanin in outbred rabbits and the F1 generation of breeding with siblings.
    Stanilova SA, Miteva LD, Tanchev SG.
    Vet Immunol Immunopathol; 2005 Jun 15; 106(1-2):15-21. PubMed ID: 15910989
    [Abstract] [Full Text] [Related]

  • 20. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA, Benaissa-Trouw BJ, Harmsen T, Erich T, Kraaijeveld CA, Snippe H.
    Immunology; 1986 Aug 15; 58(4):553-9. PubMed ID: 3015781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.